Epilepsy, Broken Bones, and Fatty Stools
Lancet 355:1882, Drenth,J.P.H.,et al, 2000
Safe Feeding Methods in Stroke Patients
Lancet 355:1662-1663, Finestone,H.M., 2000
Occupational Exposure to Methyl Isobutyl Ketone Causes Lasting Impairment in Working Memory
Neurol 54:1853-1855, Grober,E.&Schaumburg,H.H., 2000
Cytomegalovirus Ventriculoencephalitis Presenting as a Wernicke's Encephalopathy-like Sydrome
Neurol 55:1910-1913, Torgovnick,J.,et al, 2000
A 5-Month, Randomized, Placebo-controlled Trial of Galantamine in AD
Neurol 54:2269-2276, Tariot,P.N.,et al, 2000
Galantamine in AD
Neurol 54:2261-2268, Raskind,M.A.,et al, 2000
Marchiafava-Bignami Disease
Merrit's Neurology, L.P. Rowland Ed., Lippincott, Phila.:792, Miller,J.R., 2000
A Woman Who Left Her Wheelchair
Lancet 353:806, Mingrone,G.,et al, 1999
Spastic Paraparesis after Anaesthesia
Lancet 353:554, Lee,P.,et al, 1999
Neural-Tube Defects
NEJM 341:1509-1519,1485, Botto,L.D.,et al, 1999
Dementia as the Most Common Presentation of Cortical-Basal Ganglionic Degeneration
Neurol 53:1969-1974, Grimes,D.A.,et al, 1999
Treatment of Alzheimer's Disease
NEJM 341:1670-1679, Mayeux,R.&Sano,M, 1999
The Clinical Spectrum of Sarcoglycanopathies
Neurol 52:176-179, Angelini,C.,et al, 1999
Efficacy and Safety of Rivastigmine in Patients with Alzheimer's Disease:International Randomised Controlled
BMJ 318:633-640, 615, Rosler,M.,et al, 1999
Mild Cognitive Impairment, Clinical Characterization and Outcome
Arch Neurol 56:303-308, Petersen,R.C.,et al, 1999
Cost-Effectiveness of Donepezil in the Treatment of Mild or Moderate Alzheimer's Disease
Neurol 52:1138-1145,1115, Neumann,P,J.,et al, 1999
Pregnant, Vomiting, and Coma
Lancet 353:1584, Hillbom,M.,et al, 1999
Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999
Sjogren-Larsson Syndrome, Clinical and MRI/MRS Findings in FALDH-Deficient Patients
Neurol 52:1345-1352,1307, Van Domburg,P.H.M.F.,et al, 1999
Brain Structure and Neurocognitive and Behavioural Function in Adolescents Who Were Born Very Preterm
Lancet 353:1653-1657, Stewart,A.L.,et al, 1999
Intractable Epilepsy
Lancet 353:1238, Shuper,A.,et al, 1999
Presenting Features and Value of Diagnostic Procedures in Leptomeningeal Metastases
Neurol 53:382-385, van Oostenbrugge,R.J.&Twijnstra,A., 1999
Prethrombotic Disorders in Children with Arterial Ischemic Stroke and Sinovenous Thrombosis
Arch Neurol 56:967-971, Bonduel,M.,et al, 1999
Folic Acid for the Prevention of Neural Tube Defects
Pediartrics 104:325-327, Committee on Genetics, 1999
New Developments in the Neurobiology of the Tuberous Sclerosis Complex
Neurol 53:1384-1390, Crino,P.B.&Henske,E.P., 1999
Clinical Benefits of Donepezil:Results from a Long-Term Phase III Extension Trial
Neurol 52:A174, Doody,R.S.,et al, 1999
Neostigmine for the Treatment of Acute Colonic Pseudo-Obstruction
NEJM 341:137-141, Ponec,R.J.,et al, 1999
Bilteral Caudate Infarct--A Case Report
Ann Acad Med Singapore 28:569-571, Lim,J.K.H., 1999
Gastorintestinal Manifestations of Scleroderma
Gastroenterol Clin 27:563-594, Rose,S.,et al, 1998
Neuroimaging Findings in Late Infantile GM1 Gangliosidosis
AJNR 19:1628-1630, Chen,C-Y.,et al, 1998
Binocular Vertical Diplopia
Mayo Clin Proc 73:55-66, Brazis,P.W.&Lee,A.G., 1998
Dementia with Lewy Bodies:Response of Delirium-Like Features to Donepezil
Neurol 51:1512, Kaufer,D.I.,et al, 1998
Long-Term Postoperative Cognitive Dysfunction in the Elderly:ISPOCD1 Study
Lancet 351:857-861, Moller,J.T.,et al, 1998
Neurology and the Blood:Haematological Abnormalities in Ischaemic Stroke
JNNP 64:150-159, Markus,H.S.&Hambley,H., 1998
Methylphenidate in Early Poststroke Recovery:A Double-Blind, Placebo-Controlled Study
Arch Phys Med Rehabil 79:1047-1050, Grade,C.,et al, 1998
Dipsticks and Convulsions
Lancet 352:1824, Koch,H., 1998
Leukotriene C4-synthesis Deficiency:A New Inborn Error of Metabolism Linked to a Fatal Developmental Syndrome
Lancet 352:1514-1517,1487, Mayatepek,E.&Flock.B., 1998
Pregnant,Vomiting,and Going Blind
Lancet 352:1594, Tesfaye,S.,et al, 1998
Antiepileptics and Blood Dyscrasias: A Cohort Study
Pharmacotherapy 18:1277-1283, Blackburn,S.C.F.,et al, 1998
Cognitive Complaints in Patients with Whiplash Injury:The Impact of Malingering
JNNP 64:339-343, Schmand,B.,et al, 1998
Marchiafava-Bignami Disease:Reversibility of Neuroimaging Abnormality
J Comput Assist Tomogr 22:503-504, Gass,A.,et al, 1998
High Risk of Cerebral-Vein Thromb in Carriers of Prothrombin-Gene Mutation & Users of Oral Contracept
NEJM 338:1793-1797, 18401998., Martinelli,I.,et al, 1998
Atrial Fibrillation is an Independent Determinant of Low Cognitive Function
Stroke 29:1816-1820, Kilander,L.,et al, 1998
Ash-Leaf Spots in Tuberous Sclerosis
NEJM 338:1887, Kurlemann,G.&Schuierer,G., 1998
Atrophy of the Corpus Callosum, Cortical Hypometabolism, and Cognitive Impairment in Corticobasal Degeneration
Arch Neurol 55:609-614, Yamauchi,H.,et al, 1998
Fluid Attenuation Inversion Recovery (FLAIR) Images of Dentatorubropalliodoluysian Atrophy:Case Report
JNNP 65:396-399, Yoshii,F.,et al, 1998
Pharmacologic Treatment of Cognition in Alzheimer's Dementia
Neurol 51:S36-S44, Farlow,M.R.&Evans,R.M., 1998
Donepezil Improves Cognition & Global Function in Alzheimer Dis, 15-Week Doub-Blind, Plac-Contr Study
Arch Int Med 158:1021-1031, 9411998., Rogers,S.L.,et al, 1998
Intellectual Decline After Stroke, The Framingham Study
Stroke 29:805-812, Kase,C.S.,et al, 1998
Metrifonate Benefits Cognitive, Behvioral, and Global Function in Patients with Alzheimer's Disease
Neurol 50:1222-1230, 12031998., Morris,J.C.,et al, 1998